Arix Bioscience PLC (ARIX) Director/PDMR Shareholding 28-Oct-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Arix Bioscience plc ("Company")

Director/PDMR Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 50,000 Ordinary shares of 0.001 pence each in the Company ("Shares") on 26 October 2022 at a price of 1.04 pence per share and a further purchase of 25,000 shares at a price of 1.04 pence per share on 27 October 2022.

1             Details of the person discharging managerial responsibilities / person closely associated 
a)            Name 
                                                                 Peregrine Moncreiffe 
2             Reason for the notification 
a)            Position/status 
                                                                  Non-Executive Director and Chair of the Board 
b)            Initial notification /Amendment 
                                                                 Initial Notification 
3             Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction 
a)            Name 
                                                                 Arix Bioscience plc 
b)            LEI                                                213800OVT3AHQCXNIX43 
4             Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
              transaction; (iii) each date; and (iv) each place where transactions have been conducted 
a)            Description of the financial instrument, type of   Arix Bioscience plc Ordinary shares of 0.001 pence 
              instrument                                         each 
              Identification code                                GB00BD045071 
b)            Nature of the transaction 
                                                                 Share purchase 
              Price(s) and volume(s)                               Price Volume(s) 
  c)                                                               1.04 
              Aggregated information 
              - Aggregated volume                                75,000 
              - Price                                            GBP78,000 
e)            Date of the transaction                            26 October 2022 
                                                                 27 October 2022 
f)            Place of the transaction 
                                                                 Outside a trading venue 

For further information please contact: Kin Company Secretarial Limited, Company Secretary +44 20 8819 6486


ISIN:           GB00BD045071 
Category Code:  DSH 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:   197341 
EQS News ID:    1474001 
End of Announcement  EQS News Service 

Image link:


(END) Dow Jones Newswires

October 28, 2022 02:00 ET (06:00 GMT)

Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Mar 2023 to Mar 2023 Click Here for more Arix Bioscience Charts.
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Arix Bioscience Charts.